GlassScriptPhysician profile
Mark Paauw
NPI 1710515846
$2,866.03
in general payments reported to CMS, 2019-2025
9 companies · $746 in 2025
The $746 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,120 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,000 · Travel and Lodging: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,000.04 |
| Travel and Lodging | $865.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,356.44 | 2024-2025 | Luxor, Ngenuity, Clareon |
| Abbvie INC. | $448.03 | 2024-2025 | |
| Rxsight INC | $311.73 | 2024-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Glaukos Corporation | $248.87 | 2024-2025 | Idosetr, Istent, Istent Trabecular Micro-Bypass System Model Is3 |
| Sight Sciences, INC. | $239.05 | 2024-2025 | Omni Surgical System |
| New World Medical,INC. | $170.58 | 2025 | Streamline, Via360, Ahmed Glaucoma Valve |
| Harrow Eye, LLC | $72.36 | 2024-2025 | Iheezo |
| Tarsus Pharmaceuticals, INC. | $18.97 | 2025 | Xdemvy |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Paauw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.